Additionally, RNA-seq analysis of PBMC (Peripheral Blood Mononuclear Cells) obtained from a 47-year-old female patient with Acute Myeloid Leukemia (AML) with complete remission before and after induction therapy (fludarabine, cytarabine, and G-CSF (FLAG) protocol) revealed, among others, an exon 3 skipping in the TRIP12 gene [157]. Here, TRIP12 is linked to acute myeloid leukemia.